Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil

We systematically evaluated multiple and recombinant infections in an HIV-infected population selected for vaccine trials. Seventy-nine HIV-1 infected persons in a clinical cohort study in Rio de Janeiro, Brazil, were evaluated for 1 year. A combination of molecular screening assays and DNA sequenci...

Full description

Bibliographic Details
Main Authors: Artur Ramos, Amilcar Tanuri, Mauro Schechter, Mark A. Rayfield, Dale J. Hu, Maulori C. Cabral, Claudiu I. Bandea, James Baggs, Danuta Pieniazek
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 1999-02-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/5/1/99-0108_article
_version_ 1819231483842265088
author Artur Ramos
Amilcar Tanuri
Mauro Schechter
Mark A. Rayfield
Dale J. Hu
Maulori C. Cabral
Claudiu I. Bandea
James Baggs
Danuta Pieniazek
author_facet Artur Ramos
Amilcar Tanuri
Mauro Schechter
Mark A. Rayfield
Dale J. Hu
Maulori C. Cabral
Claudiu I. Bandea
James Baggs
Danuta Pieniazek
author_sort Artur Ramos
collection DOAJ
description We systematically evaluated multiple and recombinant infections in an HIV-infected population selected for vaccine trials. Seventy-nine HIV-1 infected persons in a clinical cohort study in Rio de Janeiro, Brazil, were evaluated for 1 year. A combination of molecular screening assays and DNA sequencing showed 3 dual infections (3.8%), 6 recombinant infections (7.6%), and 70 (88.6%) infections involving single viral subtypes. In the three dual infections, we identified HIV-1 subtypes F and B, F and D, and B and D; in contrast, the single and recombinant infections involved only HIV-1 subtypes B and F. The recombinants had five distinct B/F mosaic patterns: Bgag-p17/Bgag -p24/Fpol/Benv , Fgag-p17/Bgag -p24/Fpol/Fenv , Bgag-p17/B-Fgag -p24/Fpol/Fenv , Bgag-p17/B-Fgag -p24/Fpol/Benv , and Fgag-p17/B-Fgag -p24/Fpol/Fenv . No association was found between dual or recombinant infections and demographic or clinical variables. These findings indicate that dual and recombinant infections are emerging as an integral part of the HIV/AIDS epidemic in Brazil and emphasize the heterogenous character of epidemics emerging in countries where multiple viral subtypes coexist.
first_indexed 2024-12-23T11:45:41Z
format Article
id doaj.art-eec995d19fa04a70869917175f99732a
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-23T11:45:41Z
publishDate 1999-02-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-eec995d19fa04a70869917175f99732a2022-12-21T17:48:22ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60591999-02-0151657410.3201/eid0501.990108Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in BrazilArtur RamosAmilcar TanuriMauro SchechterMark A. RayfieldDale J. HuMaulori C. CabralClaudiu I. BandeaJames BaggsDanuta PieniazekWe systematically evaluated multiple and recombinant infections in an HIV-infected population selected for vaccine trials. Seventy-nine HIV-1 infected persons in a clinical cohort study in Rio de Janeiro, Brazil, were evaluated for 1 year. A combination of molecular screening assays and DNA sequencing showed 3 dual infections (3.8%), 6 recombinant infections (7.6%), and 70 (88.6%) infections involving single viral subtypes. In the three dual infections, we identified HIV-1 subtypes F and B, F and D, and B and D; in contrast, the single and recombinant infections involved only HIV-1 subtypes B and F. The recombinants had five distinct B/F mosaic patterns: Bgag-p17/Bgag -p24/Fpol/Benv , Fgag-p17/Bgag -p24/Fpol/Fenv , Bgag-p17/B-Fgag -p24/Fpol/Fenv , Bgag-p17/B-Fgag -p24/Fpol/Benv , and Fgag-p17/B-Fgag -p24/Fpol/Fenv . No association was found between dual or recombinant infections and demographic or clinical variables. These findings indicate that dual and recombinant infections are emerging as an integral part of the HIV/AIDS epidemic in Brazil and emphasize the heterogenous character of epidemics emerging in countries where multiple viral subtypes coexist.https://wwwnc.cdc.gov/eid/article/5/1/99-0108_articleBrazilUnited States
spellingShingle Artur Ramos
Amilcar Tanuri
Mauro Schechter
Mark A. Rayfield
Dale J. Hu
Maulori C. Cabral
Claudiu I. Bandea
James Baggs
Danuta Pieniazek
Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
Emerging Infectious Diseases
Brazil
United States
title Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
title_full Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
title_fullStr Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
title_full_unstemmed Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
title_short Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in Brazil
title_sort dual and recombinant infections an integral part of the hiv 1 epidemic in brazil
topic Brazil
United States
url https://wwwnc.cdc.gov/eid/article/5/1/99-0108_article
work_keys_str_mv AT arturramos dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT amilcartanuri dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT mauroschechter dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT markarayfield dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT dalejhu dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT mauloriccabral dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT claudiuibandea dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT jamesbaggs dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil
AT danutapieniazek dualandrecombinantinfectionsanintegralpartofthehiv1epidemicinbrazil